TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Medtronic; Aleviant
• Grant Support/Research Contract - Edwards Lifesciences